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Summary The care of patients with epilepsy historically has been well documented
to be poor. Previous attempts to improve care through education have been unsuc-
cessful. The New GP Contract in the UK introduced epilepsy as a core quality indicator
from April 2004. This prospective audit assesses the impact of an audit with educa-
tional intervention on the process of care of patients with epilepsy. The case notes of
610 patients, of all ages, with epilepsy on treatment, in 13 general practices serving
Chester and surrounding area were reviewed before and 2 years after an intervention,
comprising (a) the provision of a comprehensive template, (b) individualised cate-
gorisation for each patient and (c) an educational session led by a Neurologist.
The overall review rate increased in the first year from 41to 49% ( p < 0.0001) and
by 2 years to 63% ( p < 0.0001). Documented remission rate increased from 29 to 43%
( p < 0.0001). Admissions to accident and emergency fell significantly ( p = 0.0026).
There was no fall in the non-compliance rate. Forty five percent of patients with
documented poor control were not under shared care. Issues highlighted in the audit
generated 77 referrals. There were clear health gains in 62 (13%) individuals from
referrals and practice interventions related to the audit.
This original audit identified significant improvements in review rate, documented
remission rate and beneficial outcomes in individual patients. The changes were
attributable to both the educational intervention and the coincidental acceptance of
the New GP Contract. Remaining problems include lack of shared care for patients
with active epilepsy.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +44 1244 390396;
fax: +44 1244 370762.
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Evaluation of the process of care of patients with
epilepsy, including audit, intervention and re-audit,
is recommended in government-sponsored reports. Published by Elsevier Ltd. All rights reserved.
262 I. Minshall, D. Smithand national guidelines.1—3 The TIGER study,4 com-
pared the process of care for, and the quality of life
of, 1133 patients in 68 practices, after randomisa-
tion to control, intermediate, or intensive interven-
tion groups. The control practices received a
nationally developed clinical guideline5 by post
only. Intermediate intervention involved receipt
of the guideline by post supported by interactive
workshops and structured protocol documents,
while intensive intervention practices received
intermediate intervention plus a nurse specialist
who supported and educated practices in the estab-
lishment of epilepsy review clinics.
The primary outcome was the SF-366 and the
secondary outcome was a battery of pre-validated
epilepsy specific, quality of life instruments7—11.
None of the interventions were associated with
improvements in patient’s perception of quality of
life or any measures of process of care. These
included; uptake of the nurse-led intervention, an
improvement in the number of review consultations
or counselling sessions for epilepsy, and the quality
of documentation of the consultations.
We have previously reported results of a compre-
hensive audit of care of patients with epilepsy living
in Chester.12 This article describes the results of a 2
year re-audit, discusses reasons for the observed
changes, notably the coincidental acceptance of the
New GP Contract,13 limitations of this data and
implications for co-ordination of care across the
primary—secondary care interface.Methods
First audit12
The practice paper and computer records, of 610
patients of all ages with a diagnosis of epilepsy who
were receiving repeat prescriptions for anti-epilep-
tic drugs were reviewed. This took place from
December 2001 to March 2003.
Intervention
An audit template for each patient was constructed.
This included basic demographics, details of diag-
nosis, by whom, with attention directed to corre-
spondence supporting an impression of an uncertain
diagnosis, investigations, current seizure control
(whether or not in remission) and review pattern.
This concluded with individual categorisation and
recommendations as follows; patient needs GP
review, consider specialist referral, for three rea-
sons; in remission consider drug withdrawal, diag-
nostic doubt and poor seizure control. Attention wasalso drawn to those patients whose compliance was
in doubt and to women of childbearing age.
This was supplemented by a 2-h tutorial (85%
attendance of local GPs) in which Dr. Smith gave
an overview of the diagnosis and management of
epilepsy. Dr. Minshall reported back on the audit
findings for the practice concerned, on a named
patient basis.
The educational intervention was completed in
all practices after their individual audit was com-
plete and the template completed, the first session
was in December 2001 and the last March 2003. The
New GP Contract came into force in April 2004.
Re-audit
Each practice was re-visited 2 years after the initial
audit, practices 1—5 were re-audited from Decem-
ber 2003 to April 2004, practice 6—13 from July 2004
to March 2005. If a referral, or intervention, was
made in the first consultation for epilepsy after the
audit, and it related to an issue highlighted by the
audit, it was assumed to be due to the audit and
recorded accordingly. Outcomes relating to later
practice interventions, or in patients already under
shared care were documented separately.
Statistics were analysed using Graphpad compu-
ter software, using x2, proportional x2 analysis, and
with the re-audit Wilcoxon matched-pairs signed-
ranks test.Results
First audit
A summary of the findings from the first audit is
shown in Table 1.
Re-audit
There were three groups who did not complete the
audit cycle and, therefore, were not included in
review statistics.
There had been 42 deaths, none attributable to
epilepsy. Fourteen had been reviewed in the first
year, one in the second and there had been three
referrals.
Twenty patients were no longer on therapy having
had it stopped under medical supervision, 19 under
hospital care, and 1 by the GP. There was no docu-
mented recurrence of seizures in this group, all
followed up to at least 6 months.
Nineteen had stopped therapy themselves with
nomedical supervision. Twelve of these patients had
been reviewed in the post audit period. Eighteen
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Table 1 Summary of findings from the initial audit
Chester city
Population 99924
Male:female 324:286
Patients on repeat prescription 610
Shared care 138 (23%)
Reviewed in last year by GP 250 (41%)
Regular annual review 116 (19%)
No contact with any doctor
re epilepsy in last year
309 (51%)
Women of child bearing age
(16—50 years)
107 (18%)
Women of child bearing age
on valproate
37 (6%)
In remission (no seizure >1 year) 178 (29%)
‘Uncertain’ diagnosis 67 (11%)
Non-compliant 84 (14%)
Estimate of refractory epilepsy
not under shared care
45%had a firm diagnosis, 13 had been non-compliant in
the first audit. All had stopped 6 months before the
end of the audit. Three had had a recurrence of
seizures, one was unknown. One woman had
stopped medication while pregnant to restart itTable 2 Review rates overall for Chester practices
All Chester practices 1 year
pre audit
Number of patients seen in 12 months (%) 41
p-Value compared with baseline
Figure 1 Change in review rapostpartum, with no seizures. There had been
two referrals in this group.
Fifty-two patients had left their practice, eight
had been reviewed in the first year, two in the
second, and four had been referred.
Therefore, a total of 477 patients were still on
medication and completed the audit.
Table 2 illustrates the change in overall review
rate between the practices.
Individual changes between practices are shown
in Fig. 1. The numbers in brackets indicate the
number of patients in the first and second
audits. The QOF (quality and outcomes frame-
work) figures are from PCT computer downloads
at the end of the first year of the New Contract in
April 2005.14
The 13 practices can be split into two groups; the
first five could not have been influenced by the
Contract (audited December 2001—April 2002, and
re-audited December 2003—April 2004), the remain-
ing eight (audited July 2002—March 2003) would
have certainly been influenced by The Contract
particularly in year 2 (re-audited July 2004—March
2005). The differences between these two groups
are illustrated in Tables 3a and 3b.1 year
post audit
2 years
post audit
QOF April
2005
49 63 92
<0.0001 <0.0001
te over 2 years post audit.
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Table 3a Review rates in those Chester practices influenced by the education
Practices most influenced by education 1 year
pre audit
1 year
post audit
2 years
post audit
Number of patients seen in 12 months (%) 45 52 49
p-Value compared with baseline 0.0172 0.0546
Table 3b Review rates in those Chester practices influenced by the education and New Contract
Practices influenced by education and New Contract 1 year
pre audit
1 year
post audit
2 years
post audit
Number of patients seen in 12 months (%) 38 43 79
p-Value compared with baseline <0.0001 <0.0001This observation is supported by the change in the
use of templates over the two years, the audit
template was used by the practices 1—5, 84 times,
and only 14 times in practices 6—13, but the latter
group had clearly moved on to those designed for
the New Contract, using those templates 173 times,
compared to zero usage in practices 1—5.
One hundred and one were receiving shared care,
293 had seen their GP in the last year, 74 had been
seen both at the hospital and by the GP. Therefore,
33% (157/477) had not seen any doctor at all in the
previous year. This had improved from the original
audit level of 51% (p < 0.0001). One hundred and
sixty six (35%) were being seen regularly (at least
yearly) by their GP, compared with 16% in the first
audit, ( p < 0.0001).
There were 141 (30%) patients with documented
‘poor control’, of these 65 (45%) were not under
shared care, which equates to the estimate in the
first audit.Table 4 Other comparisons of care pre and post audit car
Shared care Documented remission No
First audit 23% 29% 13
Re-audit 21% 43% p < 0.0001 11
Figure 2 Change in documented remission in 2 yeThe figures have not significantly changed but of
course the shared care rate had not changed sig-
nificantly either (see below).
Other measures from the re-audit are sum-
marised in Table 4, showing there was no overall
change in the number of patients under shared care,
compliance or hospital admissions.
There was a significant increase in documented
remission and a significant decrease in A&E atten-
dance.
The change in documentation of remission is
illustrated in Fig. 2. Documentation of control was
much better in the latter stages of the audit once
the New Contract was being implemented at 43%,
but 1 year after the New Contract, the PCT figures
bring this up to 63% overall across the city. However,
even after this further increase in review rates,
there has been no change in the proportion of
patients with poor seizure control receiving shared
care.e in the Chester practices
n-compliant A&E attendance Hospital admission
% 43 27
% 19 p = 0.0026 14
ars post audit, plus QOF figures for April 2005.
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Table 6 Interventions in practice related to the audit
Reason for intervention Outcome
Uncontrolled
driving, asked to inform DVLA 1
px changed, no effect 1
In remission
declined px cessation 16
medication stopped, no
subsequent seizures
1
medication stopped, not
followed up at re-audit
1There were 77 referrals made which related to
issues highlighted in the audit, all of the original 610
patients were included in this section. Sixty-six of
these patients attended outpatients. The outcomes
of those referrals are illustrated in Table 5, those
highlighted in bold were positive outcomes.
There were 32 interventions in practice related
to the audit, illustrated in Table 6.
Of the 98 interventions related to the audit, 62
can be said to have had a positive impact on the care
of the patient.Table 5 Total number of referrals, non-attendance
and outcomes
Total number of referrals 77
Did not attend
‘uncontrolled’ 10
in remission 1
Total number of patients seen 66
Reason for referral and outcomes
Uncontrolled
non-compliant with intervention 3
px changed, no subsequent seizures 1
px changed, reduction in seizures 6
px changed, no improvement 9
px changed, side effects, changed back 1
No change, diary 11
^px, reduction in seizures 2
^px, no events 2
^px, no change 1
^med, dna 1
not yet seen 1
In remission
discussed, declined px cessation 6
medication stopped, no subsequent seizures 1
medication increased 1
Medication review
no change 1
Pre-conceptual advice
no change to px 3
Poor compliance
still poor compliance 1
Side effects
medication reduced, improved 1
Excessive medication
reduction in px, no subsequent seizures 1
Uncertain diagnosis
epilepsy confirmed 6
px stopped, no subsequent seizures 4
awaiting admission for telemetry 2
stopped px, still ‘auras’ 1
Uncertain diagnosis
epilepsy confirmed 3
discussed, no change 1
Pre-conceptual
discussed, no change 4
Poor compliance
discussed, better 1
discussed, no better 1
off px, no events 1
Change px formulation
Valproate ec, taken once daily,
changed to epilim chrono
1Discussion
This comprehensive, citywide audit of the process of
care of patients with epilepsy reveals increases in
patient review rates and proportion of patients in
documented remission. However, neither of these
measures approach the standards set by the New GP
Contract.
Furthermore, although there were tangible
benefits in some individuals we found little evi-
dence of improved seizure control, except per-
haps the significant fall in A&E attendance. It is
disappointing that the proportion of patients with
poor seizure control who were not receiving
shared care remained unacceptably high espe-
cially when the value of specialist review is well
recognised.15What changes occurred?
The overall annual review rate increased from 41 to
63%, and then 1 year after the contract to 92%. Two
practices exceeded contract standard of 90% while
six others saw more than 80% and one reviewed 65%.
Prior to the audit four practices were below the
minimum standard of 25%. While two of these
improved dramatically, the other two had not
changed.
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Although there was a significant improvement in
review rate across the city in the first year post-
intervention, there was a much more impressive
change in the following year, especially in practices
6—13 who were Contract influenced. The review
rate in practices one to five fell off in the second
year. This supports the cynical viewpoint of Davis
et al.4 that ‘primary care practitioners do not see
epilepsy care as their responsibility, and therefore
see no need to prioritise its care. If this be the case,
increased funding alone16 will not be enough to
improve the quality of patient care’. Increased
funding, in terms of The Contract certainly had a
dramatic impact on review rate, but it remains to be
seen as to the quality which accompanies this
change.Review rates were higher–—So what?
On one level it is useful to knowwhat is happening as
this permits comparison with other audit/research
and recommended standards of care.
For example, we suspected that the initial remis-
sion rate of 29% was an artefact of poor documenta-
tion.12 The rise to 43% and then 63% coincident with
the improved review rate supports that argument.
However, with the exception of one practice those
practices with greater than 80% review rates report
remission rates between 41 and 63% i.e. all below
the contract standard of 70%.
There are two possible explanations. Firstly, the
contract standard may be set too high. CSAG,1 which
sampled 1652 patients using postal questionnaires,
reported a remission rate of only 52%. Alternatively
there may be many patients in the community who
are sub-optimally diagnosed and treated. Two stu-
dies,17,15 conducted 10 years apart, report that
patients with refractory epilepsy rendered sei-
zure-free by treatment change to be 12/80 (15%)
and 17/55 (31%), respectively. Therefore, that the
proportion of patients with uncontrolled seizures
not under shared care remained as high as 46% is a
matter of concern.Patients stopping treatment
themselves
Nineteen patients had stopped medication by them-
selves, plus one pregnant woman who subsequently
restarted. A study in both primary and secondary
care settings18 concurs in observing that many
patients are uncertain about the necessity forlong-term therapy. This, in turn, may contribute
to poor or erratic compliance, which is a risk factor
for epilepsy-related sudden death.19 By highlighting
these issues to GPs this project has gone some way
to tackle these serious problems. Patients in remis-
sion merit at least one thorough discussion of the
need for long-term therapy. Ignorant of the risks of
abrupt withdrawal20 and the driving regulations21
patients will often experiment without discussion,
and stop medication of their own accord.22 For
patients who drive the evidence indicates that they
feel compelled to stay on treatment indefinitely23
and, therefore, this discussion can take place in the
GP surgery, n = 16 in this study.Compliance
Monitoring compliance is an important role for the
GP, exploring the patient’s perspective and can be
crucial to the management of non-compliance, they
often see taking medication as stigmatising.24
Referral for more information about stopping med-
ication may be helpful.25 A study of admission to a
district general hospital,26 suggested that most
admissions were due to potentially mutable pro-
blems including poor compliance rather than diffi-
cult epilepsy per se. The non-compliance rate,
similar to other primary care audits,27 did fall by
2% but this was not significant, but there was a
significant fall in A&E attendance. The initial audit
highlighted all those patients who were non-com-
plaint, at the educational session and on the tem-
plate. Despite this prompt, and there were 84 non-
compliant patients in the first audit, discussion of
the issue are documented in only three patients, one
of whom was referred.How clinically effective is the New
Contract?
The New Contract had a clear benefit in review rates
and seizure documentation. But the only clinical
requirement is to ‘review medication’, this is from
a population of clinicians who accept themselves,28
and appear to patients,29 as having a poor knowledge
of epilepsy. There is a potential to miss important
factors in the care ofpatientswith epilepsy, this audit
avoids this by reviewing and summarising the cases.
For example, the patient with a misdiagnosis on
treatment, who appears ‘controlled’; the failure to
recognise minor seizures in someone who is driving;
and thewomanof child bearing age on valproatewith
a controlled partial epilepsy who could be on a less
teratogenic drug; asking about side effects; and
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poor control should be under review by a specialist.
The dramatic improvement in review rate was not
mirrored by an equivalent rise in shared care, the
level of which fell slightly. Forty five percent of
patients with documented poor control are not under
shared care despite the education, template and
New Contract.
The first year of the New Contract was a busy,
with many targets to reach, some more financially
lucrative than epilepsy, which carries only a small
number of ‘points’. The New Contract has at least
encouraged review, maybe with time, now the first
year of box ticking is over, then some of the more
challenging issues can be addressed. But other
chronic diseases are being added to the QOF such
as renal disease and mental health, so any time for
genuine reflection is diluted. Chester was in a much
stronger position having all its patients with epilepsy
already audited with an accurate register, old notes
reviewed and summarised, plus the GPs having had
some education (85% compared with only 9.8% of all
primary care staff in the TIGER trial). The fall off in
review rate in the group affected mainly by the
educational process in the second year, implies that
education and encouragement needs to be ongoing
and yearly to sustain the improvement in care.
This project perhaps adds to the argument that
PCTs need to train and employ GPs with special
interest in epilepsy and epilepsy nurse specialists.
There is a huge workload of un-addressed issues to
be attended to. GPs have a reputation for poor
levels of knowledge of epilepsy and the ability to
give the information that patients require. A well
trained, intermediate team can fill the gap between
primary and secondary care, allowing quick efficient
referrals, with hopefully, quality outcomes.Implications for clinical practice and
future research
There should be an ongoing educational program in
each PCT on the management of epilepsy. PCTs
should consider training interested GPs to become
GPwSI in epilepsy, and nursing staff to become
epilepsy nurse specialists.
The indicators in the New Contract need some
refinement, to allow prompts for patients’ unmet
needs, such as all patients with uncontrolled epi-
lepsy should be ideally under the care of a specialist,
have side effects been discussed, is the diagnosis
correct, and has this woman of childbearing age
been properly counselled?
The audit needs to be repeated on the same
group of patients, with the New Contract havingbeen in place for 3 years, to assess the true effect of
that change.Conclusion
Acitywideaudit andeducational session, highlighting
issues relevant to each individual patient, improved
the overall review rate of patients with epilepsy
across the city. Individual issues promoted referral,
with positive outcomes, hence better quality care.
Therewas recentGovernment change,which has had
a dramatic effect on the review rate of patients with
epilepsy and some aspects of documentation. But the
relatively simplistic clinical requirements of the New
Contractpotentiallymightnotmeet the trueneedsof
this patient group. The number of patients with
documented poor control not under shared care is
still unacceptably high. PCTs need to review their
service provision for epilepsy in order to meet the
needs highlighted in this project.Acknowledgements
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